ArticlePDF Available

Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naïve adult mice

Authors:

Abstract and Figures

Ingestion of specific probiotics, namely "psychobiotics," produces psychotropic effects on behavior and affects the hypothalamic-pituitary-adrenal axis and neurochemicals in the brain. We examined the psychotropic effects of a potential psychobiotic bacterium, Lactobacillus plantarum strain PS128 (PS128), on mice subjected to early life stress (ELS) and on naïve adult mice. Behavioral tests revealed that chronic ingestion of PS128 increased the locomotor activities in both ELS and naïve adult mice in the open field test. In the elevated plus maze, PS128 significantly reduced the anxiety-like behaviors in naïve adult mice but not in the ELS mice; whereas the depression-like behaviors were reduced in ELS mice but not in naïve mice in forced swimming test and sucrose preference test. PS128 administration also reduced ELS-induced elevation of serum corticosterone under both basal and stressed states but had no effect on naïve mice. In addition, PS128 reduced inflammatory cytokine levels and increased anti-inflammatory cytokine level in the serum of ELS mice. Furthermore, the dopamine level in the prefrontal cortex (PFC) was significantly increased in PS128 treated ELS and naïve adult mice whereas serotonin (5-HT) level was increased only in the naïve adult mice. These results suggest that chronic ingestion of PS128 could ameliorate anxiety- and depression-like behaviors and modulate neurochemicals related to affective disorders. Thus PS128 shows psychotropic properties and has great potential for improving stress-related symptoms.
Content may be subject to copyright.
www.elsevier.com/locate/brainres
Available online at www.sciencedirect.com
Research Report
Psychotropic effects of Lactobacillus plantarum PS128
in early life-stressed and naïve adult mice
Yen-Wenn Liu
a
, Wei-Hsien Liu
a
, Chien-Chen Wu
a,b
, Yi-Chen Juan
a
,
Yu-Chen Wu
a
, Huei-Ping Tsai
a
, Sabrina Wang
c,
n
, Ying-Chieh Tsai
a,b,
nn
a
Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei 11221, Taiwan
b
Probiotic Research Center, National Yang-Ming University, Taipei 11221, Taiwan
c
Institute of Anatomy and Cell Biology, National Yang-Ming University, 155, Section 2, Linong Street, Taipei 11221,
Taiwan
article info
Article history:
Accepted 12 November 2015
Available online 24 November 2015
Keywords:
Dopamine
Early life stress
Hypothalamicpituitaryadrenal
axis
PS128
Psychobiotics
Serotonin
abstract
Ingestion of specic probiotics, namely psychobiotics, produces psychotropic effects on
behavior and affects the hypothalamicpituitaryadrenal axis and neurochemicals in the
brain. We examined the psychotropic effects of a potential psychobiotic bacterium,
Lactobacillus plantarum strain PS128 (PS128), on mice subjected to early life stress (ELS)
and on naïve adult mice. Behavioral tests revealed that chronic ingestion of PS128
increased the locomotor activities in both ELS and naïve adult mice in the open eld test.
In the elevated plus maze, PS128 signicantly reduced the anxiety-like behaviors in naïve
adult mice but not in the ELS mice; whereas the depression-like behaviors were reduced in
ELS mice but not in naïve mice in forced swimming test and sucrose preference test. PS128
administration also reduced ELS-induced elevation of serum corticosterone under both
basal and stressed states but had no effect on naïve mice. In addition, PS128 reduced
inammatory cytokine levels and increased anti-inammatory cytokine level in the serum
of ELS mice. Furthermore, the dopamine level in the prefrontal cortex (PFC) was
signicantly increased in PS128 treated ELS and naïve adult mice whereas serotonin (5-
HT) level was increased only in the naïve adult mice. These results suggest that chronic
ingestion of PS128 could ameliorate anxiety- and depression-like behaviors and modulate
neurochemicals related to affective disorders. Thus PS128 shows psychotropic properties
and has great potential for improving stress-related symptoms.
&2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).
http://dx.doi.org/10.1016/j.brainres.2015.11.018
0006-8993/&2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Abbreviations: CFU, colony-forming unit; CORT, corticosterone; ELS, early life stress; EPM, elevated plus maze; FST, forced
swimming test; HPA axis, hypothalamuspituitaryadrenal axis; HPLC-ECD, high-performance liquid chromatography-
electrochemical detection; IL, interleukin; LAB, lactic acid bacteria; MRS, de Man Rogosa and Sharpe; MS, maternal separation;
NELS, non-ELS; OFT, open led test; PD, postnatal day; SPT, sucrose preference test; TNF, tumor necrosis factor
n
Corresponding author.
nn
Corresponding author at: Institute of Biochemistry and Molecular Biology, National Yang-Ming University, 155, Section 2, Linong
Street, Taipei 11221, Taiwan.
E-mail addresses: sabrina@ym.edu.tw (S. Wang), tsaiyc@ym.edu.tw (Y.-C. Tsai).
brain research 1631 (2016) 1–12
1. Introduction
Probiotics are living microorganisms known to have bene-
cial effects on the host when ingested in adequate amounts
(FAO/WHO, 2001). Numerous studies have demonstrated the
diverse benets of probiotics (Vyas and Ranganathan, 2012),
including anti-inammatory effects (Liu et al., 2011), gut
protection (Zareie et al., 2006), and the attenuation of meta-
bolic dysfunctions (Barrett et al., 2012;Huang et al., 2013). In
recent years, the inuences of probiotics on the central
nervous system (CNS) and behaviors via the microbiome
gutbrain-axis have been uncovered (Collins et al., 2012). In
particular, there is an association between the gut microbiota
and stress response, and the effects of probiotics on CNS
could be mediated by humoral, immune, neural, and meta-
bolic pathways (Moloney et al., 2014;Sudo et al., 2004). Based
on the roles of probiotics in regulating stress responses and
maintaining CNS homeostasis, we think there is great poten-
tial for utilizing benecial bacteria to improve CNS-related
abnormalities.
Several probiotics have been shown to have effects on
normalizing stress-induced abnormal behaviors and regulat-
ing the hypothalamuspituitaryadrenal axis (HPA axis) and
the inammatory responses in animal models (Ait-Belgnaoui
et al., 2012;Arseneault-Breard et al., 2012;Bercik et al., 2011;
Desbonnet et al., 2010). For example, pretreatment with
probiotics in immune-decient mice has been shown to
normalize immune-mediated decits in intestinal physiology
and to affect CNS functions (Smith et al., 2014). Administra-
tion of Lactobacillus helveticuscontaining probiotics reduces
anxiety-like behaviors in rodents (Messaoudi et al., 2011;
Ohland et al., 2013). Both Bidobacterium longum 1714 and
Bidobacterium breve 1205 reduce anxiety-like behavior in an
anxious mouse strain (Savignac et al., 2014). It has also been
reported that the administration of probiotics restores mono-
amine levels in key brain regions of rats in a maternal
separation (MS) model of depression (Bercik et al., 2011;
Desbonnet et al., 2010). Also, probiotics have been shown to
alter behavior and CNS function in naïve adult animals
(Moloney et al., 2014). These ndings not only reveal the
complexity of gutbrain interactions upon stress challenge
but also suggest that probiotics could be used to ameliorate
stress-induced disorders.
Early life stress (ELS) is known to convey negative effects
on brain development and cause behavioral changes in
adulthood (Lupien et al., 2009). In rodents, MS is the most
commonly used method to create ELS for the study of the
physiological and psychological impacts of ELS (O'Mahony
et al., 2011;Sanchez et al., 2001). The affected animals show
long-lasting behavioral and physiological phenotypes, includ-
ing enhanced stress responses, anxiety-like and depression-
like behaviors, HPA axis hyperactivity, and abnormal neuro-
chemical changes (Cryan and Holmes, 2005). In addition, MS
also increases the immune response, as indicated by
enhanced IL-6 release following concanavalin A (ConA) sti-
mulation (Desbonnet et al., 2010). In humans, ELS is also
associated with immune dysregulation (Fagundes et al.,
2013). Furthermore, ELS is a well-known risk factor for
psychopathology, including major depressive disorder and
anxiety disorders (Green et al., 2010;McCrory et al., 2010;
Tyrka et al., 2013). Moreover, in animal studies MS has been
shown to affect the development of serotonergic and dopa-
minergic systems and the HPA axis in the brain (Bravo et al.,
2014;Rentesi et al., 2010). Thus, an animal model of MS is
ideal for investigating the psychopathology of stress-related
disorders and for evaluating the psychotropic potentials of
probiotics (O'Mahony et al., 2009).
Although several probiotics showing psychotropic effects
in animal models have been classied as psychobiotics,
which are dened as probiotics that produce health benets
in patients suffering from psychiatric illnesses, the eld is
still in its infancy (Dinan et al., 2013). In an attempt to screen
for potential psychobiotics in our lactic acid bacteria (LAB)
bank, we administered several LAB strains by oral gavage to
mice that underwent ELS and evaluated their psychotropic
potentials according to their ability to reverse depression-like
behaviors. Among the strains tested, we found that Lactoba-
cillus plantarum strain PS128 (PS128), isolated from sponta-
neously fermented mustard greens in Taiwan, shows the
highest potential. To our knowledge, the ability of this strain
to normalize stress-induced depression-like behaviors has
not been reported previously. Therefore, in the current study
we further characterize its psychotropic effects on the HPA
axis, immune responses, and neurochemical changes in the
brain. In addition, we also administered PS128 to naïve adult
mice to evaluate its effects on unstressed normal mice.
2. Results
2.1. PS128 causes distinct alterations in behavior in ELS
and naïve adult mice
We administered PS128 to ELS and naïve adult mice for
4 weeks and then started the behavioral tests to evaluate
the behavioral effects of chronic PS128 ingestion. The beha-
vioral tests were conducted starting from the least stressful
to the most stressful test in the following order: SPT, OFT,
EPM, and FST. In the SPT, the ELS mice showed a clear
reduction in sucrose preference compared to NELS litter-
mates; chronic ingestion of PS128 could revert this reduction
(Fig. 1A). However, chronic ingestion of PS128 had no effect on
sucrose preference in the naïve mice (Fig. 1B). In the OFT
there was no difference in the total distance traveled by the
ELS and NELS mice. However, the ELS mice showed a reduc-
tion in the time spent in the center (Fig. 2A and B). Chronic
PS128 treatment in ELS mice signicantly increased the total
distance traveled by the ELS mice but did not reverse the time
spent in the center by the mice (Fig. 2A and B); however, this
treatment signicantly increased the total distance traveled
and the time spent in the center by the naïve mice (Fig. 2C
and D).
From the EPM test we observed that ELS mice spent
signicantly more time in the closed arms than the NELS
group, indicating more anxiety-like behaviors in the ELS mice
(Fig. 3A). Although we did not observe any change in the
PS128-treated ELS mice, this treatment signicantly reduced
the closed arm time and increased open arm time of the
naïve mice (Fig. 3A and B). In contrast, in the FST, PS128
brain research 1631 (2016) 1–122
treatment signicantly reduced the immobile time in the ELS
mice, reverting the immobility to a level similar to that of the
NELS group, whereas such treatment had no effect on the
naïve mice (Fig. 4A and B). Taken together, chronic PS128
treatment increased locomotor activity in both ELS mice and
naïve rats (Fig. 2). For anxiety-like behavior evaluated by the
center time of OFT and open arm time of the EPM, PS128 had
a signicant effect on naïve mice but not ELS mice (Figs. 2 and
3). Conversely, PS128 signicantly reduced depression-like
behaviors in ELS mice but had no effect on naïve mice
(Figs. 1 and 4).
2.2. PS128 normalizes ELS-induced exaggerated
corticosterone release
Maternal neglect is known to increase stress reactivity in
offspring (Meaney, 2001). Thus, we measured the serum
corticosterone levels to access the HPA axis reactivity. During
the basal unstressed condition, the corticosterone level of the
ELS mice was signicantly higher than that of the NELS mice
(Fig. 5A). Chronic PS128 treatment signicantly reduced the
baseline corticosterone level in the ELS mice to a degree
similar to that of NELS mice (Fig. 5A). Under stressed condi-
tions, in this case 30 min after forced swimming, ELS mice
also showed signicantly higher corticosterone levels than
did the NELS mice (Fig. 5A). Again, chronic PS128 treatment
could signicantly reduce the elevated corticosterone level in
stressed ELS mice (Fig. 5A). In the naïve mice, chronic
ingestion of PS128 had no effect on the serum corticosterone
level either at baseline or under stressed conditions (Fig. 5B).
These results indicated that the HPA axis in the ELS mice was
dysregulated and administration of PS128 could normalize
the elevated corticosterone level (Fig. 5A).
Fig. 1 PS128 administration reversed the reduced sucrose preference in the ELS mice but has no effect on naïve mice. (A) ELS
mice show a clear reduction in sucrose preference compared to NELS mice, and chronic PS128 ingestion reverts this reduction
to a level similar to that of NELS mice. (B) Chronic PS128 ingestion has no effect on sucrose preference in naïve mice. ELS, early
life stress; ELSþ128, ELS mice administered PS128; NELS, non-ELS; Naïveþ128, naïve mice administered PS128. Data in the
ELS mice experiments were analyzed by one-way ANOVA; data in the naïve mice experiments were analyzed by t-test.
***po0.001.
Fig. 2 Open eld test indicates that chronic PS128 ingestion increases locomotor activities in both ELS and naïve mice and
reduces anxiety-like behaviors in naïve mice. (A) In the open eld test the total travel distance is increased in ELS mice after
PS128 administration. (B) The time spent in the center area is signicantly reduced in ELS mice, and PS128 administration had
no effect on the center time of ELS mice. (C) The total travel distance in naïve mice is also increased following PS128
administration. (D) Time spent in the center area is signicantly increased in naïve mice after chronic PS128 administration.
ELS, early life stress; ELSþ128, ELS mice administered PS128; NELS, non-ELS; Naïveþ128, naïve mice administered PS128.
Data in the ELS mice experiments were analyzed by one-way ANOVA; data in the naïve mice experiments were analyzed by t-
test. *po0.05; ***po0.001.
brain research 1631 (2016) 1–12 3
2.3. PS128 decreases ELS-induced inammation
To evaluate the effects of PS128 on the immune system of ELS
mice, we measured the levels of the pro-inammatory
cytokines TNF-αand IL-6 and the anti-inammatory cytokine
IL-10 in serum and in mitogen-stimulated splenocytes. The
ELS mice showed a signicant reduction in serum TNF-α,
whereas the IL-6 level was increased compared with that of
NELS mice (Fig. 6A and B). The IL-10 concentration of ELS
mice seemed lower than that of the NELS mice; however, this
did not reach statistical signicance (Fig. 6C). After chronic
administration of PS128, the ELS mice showed no signicant
change in TNF-αlevel (Fig. 6A). However, this treatment
signicantly reduced the IL-6 level and increased the IL-10
level in the ELS mice (Fig. 6B and C). In the cultured
splenocytes, which were obtained from NELS, ELS, and
PS128-treated ELS mice, we collected culture medium and
measured the aforementioned cytokines. We found that in
the unstimulated culture there were no differences in TNF-α,
IL-6, and IL-10 concentrations among different groups
(Fig. 6D, E and F). When we stimulated the culture with ConA,
we found that splenocytes from ELS mice produced signi-
cantly more TNF-αthan splenocytes from NELS mice (Fig. 6D).
In splenocytes from PS128-treated ELS mice, this enhance-
ment was attenuated (Fig. 6D). The level of IL-6 in LPS-
stimulated splenocytes from ELS mice was not different from
that of NELS mice; however, the IL-6 response of splenocytes
from PS128-treated ELS mice was signicantly higher than
that of the other two groups (Fig. 6E). The levels of IL-10 in
LPS-stimulated splenocytes from ELS mice showed a trend of
reduction; however, the difference was not statistically sig-
nicant. The IL-10 levels of splenocytes from the PS128-
treated ELS group were signicantly higher than those of
the ELS mice (Fig. 6F). These results showed that PS128
modulated immune responses in ELS mice. However, PS128
treatment showed no clear effects on cytokine levels in
Fig. 3 Elevated plus maze test shows PS128 administration decreases anxiety-like behaviors in naïve mice but not ELS mice.
(A) Time spent in closed arm is signicantly increased in ELS mice and PS128 administration has no effect on ELS mice. (B) In
naïve mice, PS128 administration signicantly reduced the time spent in the closed arm and increased the time spent in the
open arm. ELS, early life stress; ELSþ128, ELS mice administered PS128; NELS, non-ELS; Naïveþ128, naïve mice administered
PS128. Data of closed or open arm in the ELS mice were analyzed separately by one-way ANOVA; data of closed or open arm
in the naïve mice experiments were analyzed separately by t-test. *po0.05; ***po0.001.
Fig. 4 Forced swim test indicates PS128 administration reduces depression-like behaviors in ELS mice but not in naïve mice.
(A) The immobile time is signicantly increased in ELS mice, and PS128 administration reduces the immobile time to the level
similar to that of NELS mice. (B) PS128 administration has no effect on the immobile time of naïve mice. ELS, early life stress;
ELSþ128, ELS mice administered PS128; NELS, non-ELS; Naïveþ128, naïve mice administered PS128. Data in the ELS mice
experiments were analyzed by one-way ANOVA; data in the naïve mice experiments were analyzed by t-test. ***po0.001.
brain research 1631 (2016) 1–124
serum or stimulated splenocytes from naïve mice (data not
shown).
2.4. PS128 altered the serotonin and dopamine systems in
both ELS and naïve adult mice
Because ELS has been reported to increase serotonergic and
dopaminergic activities in the PFC, and to increase dopami-
nergic activity in the striatum (Rentesi et al., 2013), we also
investigated whether PS128 could alter the ELS-induced
changes in the serotonin and dopamine systems. We ana-
lyzed levels of 5-HT, DA, and their metabolites in the PFC and
striatum by HPLC-ECD. In the PFC, ELS mice showed signi-
cantly reduced 5-HT levels and had no change in their 5-HIAA
concentration. As a result, the ratio of 5-HIAA to 5-HT was
signicantly increased in ELS mice compared to that of NELS
mice, indicating an increase in serotonergic activity (Table 1).
Chronic PS128 ingestion did not increase the reduced 5-HT in
ELS mice, but instead reduced the 5-HIAA concentration and
consequently reduced the ratio of 5-HIAA to 5-HT to the level
similar to that of NELS mice (Table 1). However, in the naïve
adult mice PS128 increased 5-HT concentration and
decreased both the 5-HIAA concentration and the ratio of 5-
HIAA to 5-HT (Table 2). The serotonin system in the striatum
was not signicantly different in ELS, NELS, PS128-treated ELS
mice, or naïve mice (Table 1).
In the dopaminergic system, the DA concentration of PFC
tended to decrease in ELS mice compared with NELS mice;
however, this difference was not statistically signicant
(Table 1). The concentration of DA metabolite DOPAC was
not changed in ELS mice compared to NELS mice (Table 1).
However, the ratio of DOPAC to DA was signicantly higher
than that of the NELS mice (Table 1). Although the level of
HVA was signicantly reduced in ELS mice, the HVA-to-DA
ratio was not signicantly different from that of the NELS
mice (Table 1). Following chronic PS128 ingestion, the treated
ELS mice had a signicantly elevated DA level compared to
untreated ELS mice (Table 1). The DOPAC and HVA concen-
trations of PS128-treated ELS mice were also signicantly
higher than those of the untreated ELS mice. As a result, the
ratio of DOPAC to DA and HVA to DA were both signicantly
lower than that of the untreated ELS mice (Table 1). In
particular, the ratio of HVA to DA in PS128-treated mice
was even lower than that of the NELS mice (Table 1).
In naïve adult mice, PS128 treatment signicantly
increased the concentration of DA, DOPAC, and HVA
(Table 2). However, the DA turnover rate was not different
from that of the saline-treated mice (Table 2). In addition,
there was no change in the dopaminergic activity in the
striatum in ELS, PS128-treated ELS, and naïve mice groups
(Tables 1 and 2).
3. Discussion
In the present study we demonstrated the psychotropic
effects of PS128 on ELS and naïve adult mice. We used MS
as the adverse event to create ELS. MS is a well-established
paradigm used in rat models of ELS and has been shown to
result in prolonged and consistent dysfunctions in the gut
brain-axis (O'Mahony et al., 2011). Hence, it proved to be a
useful platform for screening psychobiotics (Dinan et al.,
2013). For that reason, we had adapted the rat MS procedure
with some modications because our mice had ELS. It has
been reviewed that MS in mice is difcult to work with
because it produces unreliable phenotypes that may be
caused by either different stressor protocols or mice strains
(Millstein and Holmes, 2007;Savignac et al., 2011). However,
we have consistently found that mice that underwent our
modied MS procedure developed reliable abnormal beha-
viors (Fig. 1). In addition to behavioral changes, we also found
dysfunctions in the HPA axis, immune response, and neuro-
transmitters in the ELS mice. These ndings suggest that the
modied MS procedure could be used in mice for under-
standing the adverse effects of ELS and for screening
psychobiotis.
Our ELS mice showed both anxiety-like and depression-like
phenotypes because they had reduced center time in OFT,
increased closed arm time in EPM, increased immobile time in
the FST, and reduced preference for sucrose (Figs. 14). Most
Fig. 5 Chronic PS128 administration reduces corticosterone levels in ELS mice but not naïve mice. (A) ELS treatment
signicantly elevates blood corticosterone levels under both basal and stressed states. PS128 administration effectively
reduces the corticosterone levels in the ELS mice to a level similar to that of NELS mice under both states. (B) PS128
administration has no effect on the corticosterone levels in naïve mice in both basal and stressed states. ELS, early life stress;
ELSþ128, ELS mice administered PS128; NELS, non-ELS; Naïveþ128, naïve mice administered PS128. Data of basal or stressed
state in the ELS mice experiments were analyzed separately by one-way ANOVA; data of basal or stressed state in the naïve
mice experiments were analyzed separately by t-test. *po0.05; **po0.01; ***po0.001.
brain research 1631 (2016) 1–12 5
studies using MS show a single trait consisting of either
anxiety-like or depression-like behavior (as reviewed in
Moloney et al., 2014). In addition, the serum corticosterone
levels in our ELS mice were signicantly higher in both basal
andstressedstates(Fig. 5). However, most of the MS animals in
previous studies showed increased corticosterone levels only
during the stressed state (Rees et al., 2006). These results
suggest that our ELS procedure produces a more robust
behavioral phenotype with severely dysregulated stress
response.
In our ELS mice we found a signicant increase in serum
IL-6 levels accompanied by decreased serum IL-10 levels
(Fig. 6). These changes have not been previously described
in MS rats (Desbonnet et al., 2010;O'Mahony et al., 2009).
Fig. 6 Effects of PS128 administration on serum cytokines and cytokines released from stimulated splenocytes from ELS and
naïve mice. (A) ELS treatment reduces serum TNF-αconcentration, and PS128 administration has no effect on the TNF-αlevel
of ELS mice. (B) Serum IL-6 level is signicantly elevated in ELS mice, and chronic PS128 administration reversed this
elevation. (C) Chronic PS128 administration increases serum levels of anti-inammatory cytokine IL-10 in ELS mice. (D) ConA
stimulation signicantly induced TNF-αrelease in cultured splenocytes from ELS mice. Splenocytes from PS128-treated ELS
mice show a signicant TNF-αrelease. (E) IL-6 release is signicantly elevated in splenocytes from PS128-treated ELS mice
following LPS stimulation. (F) Splenocytes from ELS mice show reduced IL-10 release following LPS stimulation, whereas the
IL-10 release in splenocytes from PS128-treated ELS mice is similar to that of NELS mice. ConA, concanavalin A; LPS,
lipopolysaccharide; ELS, early life stress; ELSþ128, ELS mice administered PS128; NELS, non-ELS. Data of serum cytokine
levels in the ELS mice experiments were analyzed by one-way ANOVA; data of medium or ConA/LPS stimulated splenocyte
experiments were analyzed separately by one-way ANOVA. *po0.05; **po0.01; ***po0.001.
brain research 1631 (2016) 1–126
Elevation of serum IL-6 is associated with stress-related
disorders in humans who had early adverse experiences
during childhood (Coelho et al., 2014). It has been shown that
adults with childhood maltreatment and patients with
depressive disorders have increased serum IL-6 levels
(Carpenter et al., 2010;Pace et al., 2006). In addition, a clinical
study has demonstrated a higher ratio of serum IL-6 to IL-10
and a lower serum IL-10 level in patients with major depres-
sion compared to patients without major depression
(Dhabhar et al., 2009). Therefore, our data suggest that the
ELS in mice could induce an immune alternation that is
similar to changes found in clinical studies. Furthermore, the
HPA axis is also known to directly interact with the immune
system (Moloney et al., 2014). Increased secretion of circulat-
ing glucocorticoids, including corticosterone, could inhibit
both innate and adaptive immune responses (Sorrells and
Sapolsky, 2007). Thus, there may be a complex cross-
regulation between the HPA axis and the immune system,
and this cross-regulation may lead to the modulation of
animal behavior. Sustained elevation of corticosterone might
also result in the reduced serum TNF-αobserved in the ELS
mice (Fig. 6A).
In addition to these ndings, concentrations of neuro-
transmitters DA and 5-HT were signicantly reduced in the
PFC of ELS mice, but there was an increase in the turnover
rate of both transmitters (Tables 1 and 2). The increased DA
Table 1 Alteration of 5-HT and DA neurochemicals in brain regions of ELS mice.
Prefrontal cortex Hippocampus Striatum
NELS ELS ELSþPS128 NELS ELS ELSþPS128 NELS ELS ELSþPS128
Monoamines and metabolites
5-HT 88.5745 42.3714
***
50.1730
*
69.774.7 52.7757.6724 5647109 6037156 6547120
5-HIAA 21.377.2 25.879.0 12.574.7
**,###
62.5721 51.9718 39.7714 77.1743 98.7750 88.8757
DA 1687114 66.1733
**
1907133
##
36.0714 29.8724 33.0712 406971176 39317938 39997939
DOPAC 50.4711 59.9729 71.2728
*
46.3721 36.279.0 34.8714 417795 4667224 333765
HVA 158751 129746 167771 72.7722 57.4710 59.0739 4597225 6877242 5197104
Turnover ratio
5-HIAA:5-HT 0.30170.38 0.61570.29
**
0.22970.12
###
0.93070.29 1.0870.55 0.73470.42 0.092470.020 0.18070.13 0.13070.058
DOPAC:DA 0.46870.28 0.83070.36
**
0.41670.18
###
1.0670.51 1.0470.36 0.93070.29 0.092370.0069 0.12370.064 0.085870.019
HVA:DA 1.6071.1 2.3171.2 0.97770.72
##
1.8170.71 1.6870.54 1.4570.35 0.16170.016 0.17970.057 0.13370.028
Concentrations of monoamines, metabolites and turnovers (ng/g wet tissue) are expressed as mean7SEM. DA, dopamine; DOPAC, 3,4-
dihydroxyphenylacetic acid; HVA, homovanillic acid; 5-HT, serotonin or 5-hydroxytryptamine; 5-HIAA, 5-hydroxyindoleacetic acid. Data were
analyzed by one-way ANOVA. Statistically signicant values are highlighted in gray.
*
po0.05;
**
po0.01;
***
po0.001 vs. NELS;
##
po0.01;
###
po0.001 vs. ELS.
Table 2 Alterations of 5-HT and DA neurochemicals in brain regions of normal adult mice.
Prefrontal cortex Hippocampus Striatum
Saline PS128 Saline PS128 Saline PS128
Monoamines and metabolites
5-HT 47.8719 95.6735
**
78.4718 99.6748 8297146 8687217
5-HIAA 25.3716 17.676.3 N/D N/D 65.3773 39.3750
DA 142766 3017157
*
50.2720 62.8749 808071070 736471883
DOPAC 95.8739 121751 57.0712 65.0718 316748 351789
HVA 123737 147742 47.177.1 54.6720 521776 469793
Turnover ratio
5-HIAA:5-HT 0.63870.64 0.16070.037 N/D N/D 0.077070.040 0.078070.044
DOPAC:DA 0.69270.34 0.54070.22 1.3170.60 1.4770.67 0.039670.0077 0.045770.017
HVA:DA 0.82370.38 0.67970.28 1.0770.40 0.98170.53 0.064770.0084 0.066710.0051
Concentrations of monoamines, metabolites and turnovers (ng/g wet tissue) are expressed as mean7SEM. DA, dopamine; DOPAC, 3,4-
dihydroxyphenylacetic acid; HVA, homovanillic acid; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, 5-hydroxytryptamine or serotonin. Data were
analyzed by t-test. Statistically signicant values are highlighted in gray. N/D, not detected.
*
po0.05;
**
po0.01 vs. Saline.
brain research 1631 (2016) 1–12 7
and 5-HT turnover rate has also been reported in the
maternal deprivation model in rats (Rentesi et al., 2013).
The serotonergic system has long been linked to anxiety,
and insufcient 5-HT concentration may lead to hyper-
excitability in the amygdala, a condition that is associated
with adulthood anxiety (Etkin and Wager, 2007). Thus,
decreased 5-HT levels in the PFC may result in dysregulated
excitability in the amygdala and consequently produce
anxiety-like behaviors in ELS mice (Fig. 3). Taken together,
our ELS procedure produced mice with multiple decits,
including abnormal behaviors, HPA dysregulation, immune
alternation, and changes in neurochemicals in the PFC.
Following the daily gavage of PS128 for 4 weeks, we found
that chronic administration of PS128 reduced the ELS-
induced depression-like behaviors, normalized the HPA axis
and immune systems, and modulated the changes in the DA
and 5-HT system in the PFC. From previous studies, ELS is
known to modulate gut microbiota and disrupt the integrity
of the gut barrier, thus resulting in increased inammation
and abnormal behaviors (O'Mahony et al., 2011), both of
which can be restored by the ingestion of benecial bacteria.
Reports have shown that consumption of a commercially
available probiotic combination of Lactobacillus rhamnosus
R0011 and Lactobacillus helveticus R0052 increases the amount
of gut lactobacilli, reduces permeability in the colon, and
reduces the elevated serum corticosterone induced by MS in
rat pups (Gareau et al., 2007). A recent study also shows that
administration of the commensal bacterium Bacteroides fragi-
lis improves gut barrier integrity and normalizes anxiety-like
behaviors in a mouse model known to display features of
autism spectrum disorder (Hsiao et al., 2013). Also, adminis-
tration of Lactobacillus farciminis has been shown to attenuate
gut hyperpermeability and the abnormal activation of the
HPA axis induced by psychological stress (Ait-Belgnaoui et al.,
2012). These results suggest that benecial bacteria in the gut
contribute to the improvement of the stress response. Thus,
it is possible that PS128 normalizes the MS-induced dysregu-
lation of the HPA axis via modulating the gut microbiota and
strengthening the gut barrier. We did not directly examine
the gut integrity of PS128-treated mice; however, judging by
the lack of effect on levels of corticosterone in PS128-treated
naïve mice, which would have normal gut microbiota and gut
barrier functions, it is likely that the effect of PS128 on the
HPA axis of ELS mice involves the improvement of gut
integrity.
Chronic treatment of PS128 also alleviated the increased
serum IL-6 concentration in ELS mice. The serum concentra-
tion of IL-6 is positively correlated with depression severity in
patients (Pace et al., 2006). Preclinical animal studies have
shown that reduction of IL-6 is associated with reducing
depression-like behaviors. For example, previous studies
show that the administration of Bidobacterium infantis 35624
to MS rats attenuated IL-6 release and reduced immobility in
FST (Desbonnet et al., 2010). Similarly, we found that chronic
PS128 administration also reduced serum IL-6 and improved
depression-like behaviors in ELS mice (Figs. 4A and 6B). We
also found that administration of PS128 signicantly
increases IL-6 production in LPS-stimulated splenocytes,
suggesting PS128 treatment could increase the function of
the immune system against foreign pathogens (Fig. 6E).
The effects of PS128 on ELS mice are clearly different from
that of the naïve mice. We found PS128 could reduce anxiety-
like behaviors in naïve mice but not ELS mice (Fig. 3). How-
ever, the depression-like behaviors were reduced in PS128-
treated ELS mice but not naïve mice (Fig. 4). In addition, PS128
treatment reduced serum corticosterone levels under both
basal and stressed conditions in ELS mice but had no effect
on naïve mice (Fig. 5). Furthermore, PS128 treatment
increased the 5-HT concentration in PFC only in naïve mice
(Table 2). Because the corticosterone response of the HPA axis
in naïve mice was not changed, the reduction of anxiety-like
behaviors in naïve mice cannot be explained by regulating
the HPA axis response. Instead, it might be related to the
increased 5-HT level in the PFC for the reason mentioned
previously, that is, that 5-HT could modulate the activity of
amygdala, which is associated with anxiety-like behavior
(Etkin and Wager, 2007). However, in ELS mice the reduced
5-HT concentration in PFC cannot be reversed by adminis-
tration of PS128, and we did not see a reduction in anxiety-
like behavior (Fig. 3 and Table 1).
Administration of PS128 increased locomotor activity in
both ELS mice and naïve mice. Previous studies have shown
that the administration of DA or its analog into specic brain
regions such as the striatum or the nucleus accumbens
stimulates locomotion in animals (Mabrouk et al., 2014;
Woodruff et al., 1976). Because we did not observe changes
in the striatal dopaminergic activity (data not shown), this
locomotor enhancement probably did not involve the stria-
tum. However, a previous study has shown that the admin-
istration of Bidobacterium infantis 35624 or citalopram to MS
rats modulated the level of noradrenaline in the brain stem
and normalized depression-like behavior (Desbonnet et al.,
2010). Changes in the noradrenaline system could also
potentially modulate the locomotor activity and should be
further explored in future studies of PS128.
The most interesting nding in this study is that PS128
signicantly reduced the hyperactive HPA axis response and
the depression-like behaviors in ELS mice (Figs. 1,4and 5).
We also found an increased DA concentration and DA turn-
over rate in the PFC of PS128-treated ELS mice (Table 1). PFC is
known to be a highly evolved brain region that is responsible
for regulating working memory, decision-making, and emo-
tions, including stress response (Shansky and Lipps, 2013).
Normal PFC function, especially regarding the reward/avoid-
ance emotional responses, requires an adequate DA concen-
tration (Arnsten, 2009). In addition, the mesocortical DA
system may have a direct inuence on the HPA axis
(Feenstra et al., 1992). Thus, the hyperactive HPA axis and
depression-like behaviors seen in ELS mice might be directly
associated with their altered DA function in the PFC (Table 1).
Interestingly, following PS128 administration, the DA system
of ELS mice was restored to the control level, and so were the
HPA axis responses and depression-like behaviors (Figs. 4,5
and Table 1). Hence, PS128 might suppress the exaggerated
release of corticosterone and normalized depression-like
behavior through increasing dopaminergic activity in the PFC.
In summary, we assessed the psychotropic effects of
PS128 in both ELS and naïve adult mice in an attempt to
identify novel psychobiotic strains. We demonstrate that
PS128 could normalize ELS-induced HPA axis hyperactivity
brain research 1631 (2016) 1–128
and depression-like behaviors, and that in naïve mice it
reduced anxiety-like behaviors. Some of the ELS-induced
serum cytokine and PFC neurochemical changes are also
restored by chronic PS128 administration. The psychotropic
effects of PS128 on ELS and naïve adult mice suggest great
potential for PS128 to be used to improve affective behaviors
under both normal and diseased conditions. In addition, to
our knowledge, PS128 is the rst psychobiotic that increases
locomotor activity and modulates both serotonergic and
dopaminergic systems, which further expands its possible
application in the treatment of psychiatric and neurological
disorders.
4. Experimental procedure
4.1. Preparation of PS128
PS128 was isolated from fermented mustard greens, which is
a traditional Hakka ethnic food product. It was identied as a
novel strain by phylogenetic classication of its 16S rDNA
sequence. The isolated PS128 was inoculated in Man Rogosa
Sharpe broth (MRS; BD Difco, Becton-Dickinson, Sparks, MD
MD, USA), cultured at 37 1C for 18 h, and then harvested by
centrifugation at 6000 gfor 10 min. The pellet was re-
suspended in MRS plus 12.5% glycerol to a nal concentration
of 5 10
9
colony-forming units per milliliter. The re-
suspended solution was then aliquoted in freezer tubes and
stored at 20 1C until use. When in use the aliquot was pre-
warmed to 37 1C for 1 h and re-suspended in saline before
being administered to mice.
4.2. Animals and housing
Timed-pregnant female and naïve adult male C57BL/6J mice
were purchased from the National Laboratory Animal Center
(Taipei, Taiwan). On arrival, the mice were accommodated in
the specic pathogen-free room at the Laboratory Animal
Center of National Yang-Ming University. The room was kept
at 22721C, 5060% humidity, and under 12 h light/dark cycle.
The mice were provided with water and chow ad libitum
(LabDiet Autoclavable Rodent Diet 5010; PMI Nutrition Inter-
national, Brentwood, MO, USA). After 1 week of acclimation
the experiments were started. All animal experimental pro-
cedures were reviewed and approved by the Institutional
Animal Care and Use Committee, National Yang-Ming Uni-
versity (IACUC No. 1001102).
4.3. Maternal separation stress
We adapted MS procedures from a rat model of ELS described
previously and made some modications (Desbonnet et al.,
2010). Briey, between postnatal day (PD) 2 and PD 14, male
and female neonates in the stress group were separated from
their mothers and littermates and placed in a small glass
bottle (5 cm in diameter) for 3 h per day (11:0014:00) at room
temperature without a heating pad (Supplementary Fig 1).
The no MS group was left with their mother undisturbed. For
the next 2 weeks, all the mice were left undisturbed except
for the routine bedding change and were weaned at PD 28. On
PD 29, only males pups were selected and were randomly
assigned to the ELS experimental group (ELSþPS128, n¼10)
and ELS control group (ELS, n¼12). Mice without MS were
regarded as the no ELS control group (NELS; n¼10).
4.4. Experimental design and sample collection
To evaluate the psychotropic effects of PS128, we administered
PS128 to the ELS experimental group and to a separate naïve
adult male group (naïve). The ELS and naïve experimental
groups were given saline re-suspended PS128 daily (10
9
CFU/
mouse/day) by gavage for 4 weeks from PD 29 and from 8 weeks
old, respectively, whereas the ELS and naïve control groups were
given saline by gavage during the same period. At the end of the
PS128 treatment period, when ELS group mice were 8 weeks old
andnaïvegroupmicewere12weeksold,themiceunderwenta
battery of behavioral tests. The tests were given in sequence
from the least stressful to the most stressful in the following
order: sucrose preference test (SPT); open eld test (OFT);
elevated plus maze (EPM); and forced swimming test (FST). After
the 4-day SPT the mice were subjected to OFT on the next day.
EPM test were conducted immediately after OFT on the same
test day. On the next day the rst session of FST began. All the
tests were conducted during the light phase.
On the last day of FST, before the swim start, the mice were
subjected to orbital sinus blood collection to obtain the basal
state samples. Then, the mice underwent a 6-min forced swim
and were returned to their home cage. After 30 min, blood
samples were collected again to obtain the stressed state
samples. All blood sampling was conducted within the same
3-hperiodinanefforttominimize the effect of circadian rhythm
on corticosterone release. The collected whole blood was cen-
trifuged at 3000 gfor 10 min at 4 1C, and then the serum was
stored at 80 1C until use. Following blood collection, the mice
were sacriced by cervical dislocation. The brains were quickly
removed and placed on dry ice. The ice-cold brain was dissected
on a lter paper placed on a glass dish on ice. The prefrontal
cortex (PFC), hippocampus, and striatum samples were dissected
out and immediately preserved in ice-cold 0.6% perchloric acid
and stored at 80 1C until use. Spleen tissues were also
collected, temporarily stored in ice-cold RPMI 1640 medium
(Invitrogen, Carlsbad, CA, USA), and then processed in spleno-
cyte experiments (see mitogen-stimulated splenocyte section).
4.5. Sucrose preference test
SPT was modied from a previous study by Yu et al. (2012).To
habituate the mice to drinking sucrose-containing solution,
on the rst day of the test the mice were given two bottles of
1% sucrose solution (g/mL) at 18:00 for 24 h. On the second
day, one of the sucrose bottles was replaced with tap water
and left for 24 h. On the third day, the mice were water-
deprived for 18 h from 18:00 until 12:00 next day. On the
fourth day, immediately after water deprivation, the mice
were given one bottle of 1% sucrose and one bottle of tap
water for 5 h. The position of the bottles was switched to
avoid location preference. The sucrose and water consumed
during the 5-h test were measured. The sucrose preference
(%) was calculated as follows: (weight of sucrose consumed/
total weight of sucrose and water consumed) 100.
brain research 1631 (2016) 1–12 9
4.6. Open eld test
Locomotor activity of the mice was examined by the OFT. In
this test the mouse was placed in the open eld activity
chamber for 10 min (Tru Scan Activity System; Coulbourn
Instruments, Whitehall, PA, USA). The square activity cham-
ber (25.4 25.4 38 cm
3
) is made of Plexiglas walls with two
photobeam sensor bars on each side. The box was cleaned
with 70% ethanol after each test. The activities were auto-
matically recorded and quantied with the Tru Scan 2.2 soft-
ware (Coulbourn Instruments). The total distance traveled,
moving time, and center distance and time were measured by
the Tru Scan Activity System. The center area was dened as
a region in the center measuring 12.5 12.5 cm
2
.
4.7. Elevated plus maze test
The elevated plus maze is composed of two closed arms and two
open arms (height, 45 cm; full arm length, 66 cm; arm width,
10 cm; wall height of closed arm, 30 cm). This test was used to
assess anxiety-like behavior of the mice. The mouse was placed
in the center arm crossing area (10 10 cm
2
)andallowedfree
exploration in the maze for 10 min. The maze was cleaned with
70% ethanol after each test. The mouse activity was recorded by
a video camera mounted on the ceiling of the maze center. The
recorded activity was later analyzed by EthoVision video tracking
software (Noldus Information Technology, Wageningen, the
Netherlands). The total travel distance and duration spent in
the open and closed arms were quantied.
4.8. Forced swimming test
The FST was used to assess the depression-like behaviors in the
mice. Briey, mice were put in a transparent acrylic cylinder
(height, 30 cm; internal diameter, 10 cm) containing 15 cm water
(2325 1C) to swim for 6 min on the rst day. After the swim, the
mice were dried with tissue paper and returned to their home
cage. The next day, the mice were given a second swim session
for 5 min. Only naïve adult mice were subjected to the rst and
second sessions of FST. Mice in the ELS experiments underwent
only the rst day session. The swim sessions were recorded by a
video camera and the behavior was analyzed by EthoVision
video tracking software. The immobile time were quantied
from the rst day session of ELS groups and from the second day
session of naïve adult mice.
4.9. Serum corticosterone
The serum was diluted rst, and then we used a commercial
CORT EIA kit (Cayman Chemical, Michigan, MI, USA) to
analyze corticosterone concentration. The corticosterone
concentration was interpolated using the standards provided
in the kit following the manufacturers instructions.
4.10. Serum cytokine
We measured cytokine levels in the serum samples collected
during the baseline period and in the culture medium of
stimulated splenocytes. Tumor necrosis factor (TNF)-α, inter-
leukin (IL)-6, and IL-10 were measured using commercial
ELISA kits (eBioscience, San Diego, CA, USA) according to
the manufacturers instructions.
4.11. Mitogen-stimulated splenocytes
Spleen preserved in ice-cold RPMI 1640 medium was rst
squashed by a sterile piston and then ltered through a sieve
mesh cell strainer (Becton, Dickinson and Company, East
Rutherford, NJ, USA) to isolate single cells. The preparation
was centrifuged at 1000 rpm for 5 min. The pellet was
collected and treated with lysis buffer for 5 min to remove
erythrocyte. Then, the preparation was centrifuged again to
remove lysis buffer and washed in serum-free RPMI 1640
medium. After the nal centrifugation to remove serum-free
medium, the splenocyte pellet was re-suspended in RPMI
1640 medium plus 10% fetal bovine serum and seeded at
210
6
cells/200 μL/well in 96-well at-bottom plates. The
stimulated splenocytes were cultured with mitogen conca-
navalin A (ConA; 4 μg/mL) or lipopolysaccharide (LPS;
0.6 μg/mL) in the culture medium for 48 h at 37 1C (5% CO
2
).
The control splenocytes were cultured for the same period of
time without mitogens.
4.12. Quantication of monoamines and metabolites
The frozen PFCs, hippocampus, and striata were thawed and
homogenized with a micro-sonicator (Q125 sonicator; Qsonica,
Newton, CT, USA). The homogenized samples were then cen-
trifuged at 12,000 gfor 10 min at 4 1C. The supernatants were
ltered through a 0.22-mm polyvinylidene diuoride membrane
(4-mm syringe lter; Millex-GV; Millipore, Billerica, MA, USA).
Afterproperdilutionwetook20-μl samples to measure the
concentrations of monoamines and their metabolites by the
high-performance liquid chromatography-electrochemical
detection system (HPLC-ECD). The HPLC-ECD comprised a
micropump (CMA-100; CMA, Stockholm, Sweden), an online
injector (CMA-160), a Microtech LC-pump (Microtech Scientic,
Sunnyvale, CA, USA), a BAS-4C electrochemical detector (Bioa-
nalytical Systems, Inc., West Lafeyette, IN, USA), and a reversed-
phase column (Kinetex C
18
,2.6μm, 100 2.1 mm I.D.; Phenom-
enex, Torrance, CA, USA) as previously described (Cheng et al.,
2000). The potential for the glassy carbon working electrode was
set at þ650 mV with respect to an Ag/AgCl reference electrode at
room temperature (25 1C). The mobile phase containing 0.1 M
NaH
2
PO
4
, 8% methanol, 0.74 mM SOS (1-octanesulfonic acid,
sodium salt), 0.03 mM EDTA, and 2 mM KCl was adjusted to pH
3.74 with H
3
PO
4
.Dilutedltrates were then injected (20 μL) into
the chromatographic system at a ow rate of 0.2 mL/min.
Concentrations of DA, 3,4-dihydroxyphenylacetic acid (DOPAC),
homovanillic acid (HVA), 5-HT, and 5-hydroxyindoleacetic acid
(5-HIAA) in the samples were interpolated using standards
(Sigma-Aldrich, St. Louis, MO, USA) ranging from 1 to 100 ng/mL.
4.13. Statistical analysis
All data were expressed as mean7SEM. Differences between
groups were analyzed by one-way or two-way analysis of
variance (ANOVA) with Bonferronis post-test or two-tailed t-
test when appropriate.
brain research 1631 (2016) 1–1210
Contributions
WSL, YCJ, and YCT designed the study. WSL, YCJ, YCW, and
HPT performed the experiments. WSL, SW, and YCJ analyzed
and interpreted the data. YWL, SW, WSL, CCW, YCJ, and YCT
wrote the manuscript.
Disclosure
The authors have declared no conict of interest related to
this study.
Acknowledgments
We thank Prof. Tung-Hu Tsai for providing the HPLC-ECD
system, Ko-Fan Lu and Heng-Chun Lin for contributing part
of the work, and Dr. Wang-Tso Lee and Dr. Cheng-Jee Hong
for helpful discussions. This work was supported by the
Academic Technology Development Program (101-EC-17-A-
17-S1-197) of the Ministry of Economic Affairs, Republic of
China. The funding source had no contribution to the study
design, collection, analysis, interpretation of the data, or
writing of the report for publication.
Appendix A. Supplementary material
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.brainres.
2015.11.018.
references
Ait-Belgnaoui, A., Durand, H., Cartier, C., Chaumaz, G., Eutamene,
H., Ferrier, L., Houdeau, E., Fioramonti, J., Bueno, L., Theo-
dorou, V., 2012. Prevention of gut leakiness by a probiotic
treatment leads to attenuated HPA response to an acute
psychological stress in rats. Psychoneuroendocrinology 37,
1885–1895.
Arnsten, A.F., 2009. Stress signalling pathways that impair pre-
frontal cortex structure and function. Nat. Rev. Neurosci. 10,
410–422.
Arseneault-Breard, J., Rondeau, I., Gilbert, K., Girard, S.A., Tomp-
kins, T.A., Godbout, R., Rousseau, G., 2012. Combination of
Lactobacillus helveticus R0052 and Bidobacterium longum R0175
reduces post-myocardial infarction depression symptoms and
restores intestinal permeability in a rat model. Br. J. Nutr. 107,
1793–1799.
Barrett, E., Fitzgerald, P., Dinan, T.G., Cryan, J.F., Ross, R.P., Quigley,
E.M., Shanahan, F., Kiely, B., Fitzgerald, G.F., O’Toole, P.W.,
Stanton, C., 2012. Bidobacterium breve with alpha-linolenic
acid and linoleic acid alters fatty acid metabolism in the
maternal separation model of irritable bowel syndrome. PLoS
One 7, e48159.
Bercik, P., Park, A.J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X.,
Deng, Y., Blennerhassett, P.A., Fahnestock, M., Moine, D.,
Berger, B., Huizinga, J.D., Kunze, W., McLean, P.G., Bergonzelli,
G.E., Collins, S.M., Verdu, E.F., 2011. The anxiolytic effect of
Bidobacterium longum NCC3001 involves vagal pathways for
gut–brain communication. Neurogastroenterol. Motil. 23,
1132–1139.
Bravo, J.A., Dinan, T.G., Cryan, J.F., 2014. Early-life stress induces
persistent alterations in 5-HT1A receptor and serotonin
transporter mRNA expression in the adult rat brain. Front.
Mol. Neurosci. 7, 24.
Carpenter, L.L., Gawuga, C.E., Tyrka, A.R., Lee, J.K., Anderson, G.
M., Price, L.H., 2010. Association between plasma IL-6
response to acute stress and early-life adversity in healthy
adults. Neuropsychopharmacology 35, 2617–2623.
Cheng, F.C., Kuo, J.S., Huang, H.M., Yang, D.Y., Wu, T.F., Tsai, T.H.,
2000. Determination of catecholamines in pheochromocy-
toma cell (PC-12) culture medium by microdialysis-microbore
liquid chromatography. J. Chromatogr. A 870, 405–411.
Coelho, R., Viola, T.W., Walss-Bass, C., Brietzke, E., Grassi-Oliveira,
R., 2014. Childhood maltreatment and inflammatory markers:
a systematic review. Acta Psychiatr. Scand. 129, 180–192.
Collins, S.M., Surette, M., Bercik, P., 2012. The interplay between
the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10,
735–742.
Cryan, J.F., Holmes, A., 2005. The ascent of mouse: advances in
modelling human depression and anxiety. Nat. Rev. Drug
Discov. 4, 775–790.
Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J.F., Dinan, T.
G., 2010. Effects of the probiotic Bidobacterium infantis in the
maternal separation model of depression. Neuroscience 170,
1179–1188.
Dhabhar, F.S., Burke, H.M., Epel, E.S., Mellon, S.H., Rosser, R., Reus,
V.I., Wolkowitz, O.M., 2009. Low serum IL-10 concentrations
and loss of regulatory association between IL-6 and IL-10 in
adults with major depression. J. Psychiatr. Res. 43, 962–969.
Dinan, T.G., Stanton, C., Cryan, J.F., 2013. Psychobiotics: a novel
class of psychotropic. Biol. Psychiatry 74, 720–726.
Etkin, A., Wager, T.D., 2007. Functional neuroimaging of anxiety: a
meta-analysis of emotional processing in PTSD, social anxiety
disorder, and specific phobia. Am. J. Psychiatry 164, 1476–1488.
Fagundes, C.P., Glaser, R., Kiecolt-Glaser, J.K., 2013. Stressful early
life experiences and immune dysregulation across the life-
span. Brain Behav. Immun. 27, 8–12.
FAO/WHO, 2001. Health and Nutritional Properties of Probiotics in
Food Including Powder Milk With Live Lactic Acid Bacteria.
Cordoba, Argentina.
Feenstra, M.G., Kalsbeek, A., van Galen, H., 1992. Neonatal lesions
of the ventral tegmental area affect monoaminergic responses
to stress in the medial prefrontal cortex and other dopamine
projection areas in adulthood. Brain Res. 596, 169–182.
Gareau, M.G., Jury, J., MacQueen, G., Sherman, P.M., Perdue, M.H.,
2007. Probiotic treatment of rat pups normalises corticoster-
one release and ameliorates colonic dysfunction induced by
maternal separation. Gut 56, 1522–1528.
Green, E.K., Grozeva, D., Jones, I., Jones, L., Kirov, G., Caesar, S.,
Gordon-Smith, K., Fraser, C., Forty, L., Russell, E., Hamshere,
M.L., Moskvina, V., Nikolov, I., Farmer, A., McGuffin, P., Well-
come Trust Case Control, C., Holmans, P.A., Owen, M.J.,
O’Donovan, M.C., Craddock, N., 2010. The bipolar disorder risk
allele at CACNA1C also confers risk of recurrent major
depression and of schizophrenia. Mol. Psychiatry 15,
1016–1022.
Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue,
T., Codelli, J.A., Chow, J., Reisman, S.E., Petrosino, J.F., Patter-
son, P.H., Mazmanian, S.K., 2013. Microbiota modulate beha-
vioral and physiological abnormalities associated with
neurodevelopmental disorders. Cell 155, 1451–1463.
Huang, H.Y., Korivi, M., Tsai, C.H., Yang, J.H., Tsai, Y.C., 2013.
Supplementation of Lactobacillus plantarum K68 and fruit–
vegetable ferment along with high fat–fructose diet attenu-
ates metabolic syndrome in rats with insulin resistance. Evid.
Based Complement. Altern. Med. 2013, 943020.
brain research 1631 (2016) 1–12 11
Liu, Y.W., Su, Y.W., Ong, W.K., Cheng, T.H., Tsai, Y.C., 2011. Oral
administration of Lactobacillus plantarum K68 ameliorates DSS-
induced ulcerative colitis in BALB/c mice via the anti-
inflammatory and immunomodulatory activities. Int. Immu-
nopharmacol. 11, 2159–2166.
Lupien, S.J., McEwen, B.S., Gunnar, M.R., Heim, C., 2009. Effects of
stress throughout the lifespan on the brain, behaviour and
cognition. Nat. Rev. Neurosci. 10, 434–445.
Mabrouk, O.S., Semaan, D.Z., Mikelman, S., Gnegy, M.E., Kennedy,
R.T., 2014. Amphetamine stimulates movement through tha-
lamocortical glutamate release. J. Neurochem. 128, 152–161.
McCrory, E., De Brito, S.A., Viding, E., 2010. Research review: the
neurobiology and genetics of maltreatment and adversity. J.
Child Psychol. Psychiatry 51, 1079–1095.
Meaney, M.J., 2001. Maternal care, gene expression, and the
transmission of individual differences in stress reactivity
across generations. Annu. Rev. Neurosci. 24, 1161–1192.
Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi,
A., Bisson, J.F., Rougeot, C., Pichelin, M., Cazaubiel, M.,
Cazaubiel, J.M., 2011. Assessment of psychotropic-like prop-
erties of a probiotic formulation (Lactobacillus helveticus R0052
and Bidobacterium longum R0175) in rats and human subjects.
Br. J. Nutr. 105, 755–764.
Millstein, R.A., Holmes, A., 2007. Effects of repeated maternal
separation on anxiety- and depression-related phenotypes in
different mouse strains. Neurosci. Biobehav. Rev. 31, 3–17.
Moloney, R.D., Desbonnet, L., Clarke, G., Dinan, T.G., Cryan, J.F.,
2014. The microbiome: stress, health and disease. Mamm.
Genome 25, 49–74.
O’Mahony, S.M., Marchesi, J.R., Scully, P., Codling, C., Ceolho, A.M.,
Quigley, E.M., Cryan, J.F., Dinan, T.G., 2009. Early life stress
alters behavior, immunity, and microbiota in rats: implica-
tions for irritable bowel syndrome and psychiatric illnesses.
Biol. Psychiatry 65, 263–267.
O’Mahony, S.M., Hyland, N.P., Dinan, T.G., Cryan, J.F., 2011.
Maternal separation as a model of brain–gut axis dysfunction.
Psychopharmacology 214, 71–88.
Ohland, C.L., Kish, L., Bell, H., Thiesen, A., Hotte, N., Pankiv, E.,
Madsen, K.L., 2013. Effects of Lactobacillus helveticus on murine
behavior are dependent on diet and genotype and correlate
with alterations in the gut microbiome. Psychoneuroendocri-
nology 38, 1738–1747.
Pace, T.W., Mletzko, T.C., Alagbe, O., Musselman, D.L., Nemeroff,
C.B., Miller, A.H., Heim, C.M., 2006. Increased stress-induced
inflammatory responses in male patients with major depres-
sion and increased early life stress. Am. J. Psychiatry 163,
1630–1633.
Rees, S.L., Steiner, M., Fleming, A.S., 2006. Early deprivation, but
not maternal separation, attenuates rise in corticosterone
levels after exposure to a novel environment in both juvenile
and adult female rats. Behav. Brain Res. 175, 383–391.
Rentesi, G., Antoniou, K., Marselos, M., Fotopoulos, A., Alboy-
charali, J., Konstandi, M., 2010. Long-term consequences of
early maternal deprivation in serotonergic activity and HPA
function in adult rat. Neurosci. Lett. 480, 7–11.
Rentesi, G., Antoniou, K., Marselos, M., Syrrou, M., Papadopoulou-
Daifoti, Z., Konstandi, M., 2013. Early maternal deprivation-
induced modifications in the neurobiological, neurochemical
and behavioral profile of adult rats. Behav. Brain Res. 244,
29–37.
Sanchez, M.M., Ladd, C.O., Plotsky, P.M., 2001. Early adverse
experience as a developmental risk factor for later psycho-
pathology: evidence from rodent and primate models. Dev.
Psychopathol. 13, 419–449.
Savignac, H.M., Dinan, T.G., Cryan, J.F., 2011. Resistance to early-
life stress in mice: effects of genetic background and stress
duration. Front. Behav. Neurosci. 5, 13.
Savignac, H.M., Kiely, B., Dinan, T.G., Cryan, J.F., 2014. Bifidobac-
teria exert strain-specific effects on stress-related behavior
and physiology in BALB/c mice. Neurogastroenterol. Motil. 26,
1615–1627.
Shansky, R.M., Lipps, J., 2013. Stress-induced cognitive dysfunc-
tion: hormone-neurotransmitter interactions in the prefrontal
cortex. Front. Hum. Neurosci. 7, 123.
Smith, C.J., Emge, J.R., Berzins, K., Lung, L., Khamishon, R., Shah,
P., Rodrigues, D.M., Sousa, A.J., Reardon, C., Sherman, P.M.,
Barrett, K.E., Gareau, M.G., 2014. Probiotics normalize the gut–
brain–microbiota axis in immunodeficient mice. Am. J. Phy-
siol. Gastrointest. Liver Physiol. 307, G793–G802.
Sorrells, S.F., Sapolsky, R.M., 2007. An inflammatory review of
glucocorticoid actions in the CNS. Brain Behav. Immun. 21,
259–272.
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., Kubo,
C., Koga, Y., 2004. Postnatal microbial colonization programs
the hypothalamic-pituitary-adrenal system for stress
response in mice. J. Physiol. 558, 263–275.
Tyrka, A.R., Burgers, D.E., Philip, N.S., Price, L.H., Carpenter, L.L.,
2013. The neurobiological correlates of childhood adversity
and implications for treatment. Acta Psychiatr. Scand. 128,
434–447.
Vyas, U., Ranganathan, N., 2012. Probiotics, prebiotics, and
synbiotics: gut and beyond. Gastroenterol. Res. Pract. 2012,
872716.
Woodruff, G.N., Kelly, P.H., Elkhawad, A.O., 1976. Effects of
dopamine receptor stimulants on locomotor activity of rats
with electrolytic or 6-hydroxydopamine-induced lesions of
the nucleus accumbens. Psychopharmacologia 47, 195–198.
Yu, H., Wang, D.D., Wang, Y., Liu, T., Lee, F.S., Chen, Z.Y., 2012.
Variant brain-derived neurotrophic factor Val66Met poly-
morphism alters vulnerability to stress and response to
antidepressants. J. Neurosci. 32, 4092–4101.
Zareie, M., Johnson-Henry, K., Jury, J., Yang, P.C., Ngan, B.Y.,
McKay, D.M., Soderholm, J.D., Perdue, M.H., Sherman, P.M.,
2006. Probiotics prevent bacterial translocation and improve
intestinal barrier function in rats following chronic psycho-
logical stress. Gut 55, 1553–1560.
brain research 1631 (2016) 1–1212
... A solid basis for therapeutic application has been established by the encouraging advantages of probiotics in depression, as demonstrated by both in vitro and in vivo investigations [164,165]. Table 2 Ref. [166][167][168][169][170][171][172][173][174][175][176][177][178][179][180][181]) lists a few probiotic microbes that have been studied for their potential to reduce anxiety or depression. By lowering oxidative stress, modifying the cytokine milieu to mitigate the levels of proinflammatory factors such as cytokines, and/or changing brain hormones or neurotrophic factors, psychobiotics lessen anxiety, depression, and neurodegeneration in hosts. ...
... Additionally, the mode of action of psychobiotics varies depending on the strain, with different strains of the same species having different mechanisms for lowering psychological stress [166]. Table 2 describes the role of psychobiotics in relieving depression and various comorbid disorders [167][168][169][170][171][172][173][174][175][176][177][178][179][180][181][182]. One milliliter of solution per day comprising 10 10 colony forming unit (CFU)/g Enhancement of the behavioral responsiveness and decreased corticosterone serum levels [167] Faecalibacteriumprausnitzii Mild stressors exposed to Sprague-Dawley rats Total for four weeks, 1 × 10 9 CFU/mL Showed antidepressant antianxiety-like effects and increased IL-10, IL-6, Short-chain fatty acids (SCFAs), and corticosterone concentration [168] Ecologic obstacle L. acidophilus W37, B. lactis W52, B. lactis W51, and B. bifidum W23. ...
... billion CFU for 30 days (1.5 gm per stick) Less stress on the brain and, reduced urinary free cortisol in rats and human subjects[180,181]. ...
Article
Full-text available
The human gut has 12 distinct phyla, among which Proteobacteria, Firmicutes, Actinobacteria, and Bacteroidetes make up ˃90%. Depressed individuals are a significant phylum and are differentiated from healthy individuals by their firmicutes. The micro-biome is a key component of the pathological basis of major depressive illness as a result of disruption of the microbiota-gut-brain (MGB) axis. The fact is that there is bidirectional communication inside the brain, stomach, and brain-gut, wherein the brain highlights a systemic disease characterized by both brain and peripheral dysfunction. According to the microbiota hypothesis, MGB axis dysfunction is a significant contributor to the pathogenic underpinnings of major depressive disorder (MDD). The etiology of MDD is complicated and includes an imbalance of neurotransmitters, an impaired hypothalamic-pituitary-adrenal (HPA) axis, inflammation, and the MGB axis. According to research, having an aberrant microbiome or a disjointed MGB axis may directly cause psychiatric diseases such as MDD. Hence, resolving these issues may help with depression symptoms. Probiotics may therefore have therapeutic benefits for psychiatric symptoms by fostering healthy and balanced gut flora. The probiotic Bifidobacterium longum NCC3001 has been shown to reduce depression scores. In this review, the unknown mysteries and myths of probiotics are unlocked with special attention given to MDD or depression.
... Studies have also identified the positive effects of psychobiotics using distinct strains of probiotic bacteria. In a study by Liu et al. (2016), naïve adult mice and mice under stress in early life were administered 1 × 10 9 CFU of Lactobacillus plantarum PS128 [160]. An open field test showed that the administration of Lactobacillus plantarum PS128 increased psychomotor activity in both stressed and naïve adult mice in early life. ...
... Studies have also identified the positive effects of psychobiotics using distinct strains of probiotic bacteria. In a study by Liu et al. (2016), naïve adult mice and mice under stress in early life were administered 1 × 10 9 CFU of Lactobacillus plantarum PS128 [160]. An open field test showed that the administration of Lactobacillus plantarum PS128 increased psychomotor activity in both stressed and naïve adult mice in early life. ...
... The levels of inflammatory cytokines also decreased, while serum anti-inflammatory cytokines increased in the mice stressed early in life. The dopamine levels in the prefrontal cortex were elevated in both treated groups, while the serotonin levels were elevated only in the naïve adult mice [160]. Another study confirming the beneficial effects of psychobiotics on animal models of depression conducted by Tian et al. [161] has identified the psychobiotic potential of Bifidobacterium breve CCFM1025. ...
Article
Full-text available
The microbiota–gut–brain (MGB) axis is a complex communication network linking the gut, microbiota, and brain, influencing various aspects of health and disease. Dysbiosis, a disturbance in the gut microbiome equilibrium, can significantly impact the MGB axis, leading to alterations in microbial composition and function. Emerging evidence highlights the connection between microbiota alterations and neurological and psychiatric disorders, including depression. This review explores the potential of psychobiotics in managing depressive disorders, emphasizing their role in restoring microbial balance and influencing the MGB axis. Psychobiotics exhibit positive effects on the intestinal barrier, immune response, cortisol levels, and the hypothalamic–pituitary–adrenal (HPA) axis. Studies suggest that probiotics may serve as an adjunct therapy for depression, especially in treatment-resistant cases. This review discusses key findings from studies on psychobiotics interventions, emphasizing their impact on the gut–brain axis and mental health. The increasing acceptance of the expanded concept of the MGB axis underscores the importance of microorganisms in mental well-being. As our understanding of the microbiome’s role in health and disease grows, probiotics emerge as promising agents for addressing mental health issues, providing new avenues for therapeutic interventions in depressive disorders.
... 18,19 Previously, we demonstrated that Lactiplantibacillus plantarum PS128 (PS128) increases dopamine and serotonin levels in the striatum, reducing anxiety-and depression-like behaviors in mice. 20 Clinical studies have further demonstrated that PS128 supplementation reduces oppositional/defiant behavior, improves attention and communication skills, and increases personal autonomy in patients with ASD. 21,22 Recently, the administration of probiotics to improve ASD-associated behaviors has become a key focus of clinical research. ...
... L. plantarum PS128 (PS128) was cultured and prepared according to a previously published method. 20 Briefly, cryopreserved PS128 was awakened by anaerobic culture in De Man-Rogosa-Sharpe broth (BD Difco, Becton-Dickinson) at 37°C for 18 h, and then centrifuged at 6000×g for 10 min. The supernatants were removed, and the bacterial pellets were washed with saline and then centrifuged at 6000×g for 10 min. ...
Article
Full-text available
Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting over 1% of the global population. Individuals with ASD often exhibit complex behavioral conditions, including significant social difficulties and repetitive behaviors. Moreover, ASD often co-occurs with several other conditions, including intellectual disabilities and anxiety disorders. The etiology of ASD remains largely unknown owing to its complex genetic variations and associated environmental risks. Ultimately, this poses a fundamental challenge for the development of effective ASD treatment strategies. Previously, we demonstrated that daily supplementation with the probiotic Lactiplantibacillus plantarum PS128 (PS128) alleviates ASD symptoms in children. However, the mechanism underlying this improvement in ASD-associated behaviors remains unclear. Here, we used a well-established ASD mouse model, induced by prenatal exposure to valproic acid (VPA), to study the physiological roles of PS128 in vivo. Overall, we showed that PS128 selectively ameliorates behavioral abnormalities in social and spatial memory in VPA-induced ASD mice. Morphological examination of dendritic architecture further revealed that PS128 facilitated the restoration of dendritic arborization and spine density in the hippocampus and prefrontal cortex of ASD mice. Notably, PS128 was crucial for restoring oxytocin levels in the paraventricular nucleus and oxytocin receptor signaling in the hippocampus. Moreover, PS128 alters the gut microbiota composition and increases the abundance of Bifidobacterium spp. and PS128-induced changes in Bifidobacterium abundance positively correlated with PS128-induced behavioral improvements. Together, our results show that PS128 treatment can effectively ameliorate ASD-associated behaviors and reinstate oxytocin levels in VPA-induced mice, thereby providing a promising strategy for the future development of ASD therapeutics.
... Prolonged neurotransmitter deficiency can lead to neuronal and synaptic degeneration, thereby triggering neurodegenerative diseases such as AD and PD [72] . For example, the decrease of serotonin (5-HT) in the brain is a prevalent pathological characteristic of anxiety disorders, depression, AD, and PD patients [73,74] . Supplementation with probiotics, such as Lactobacillus plantarum PS128, can increase the concentrations of dopamine (DA) and 5-HT in the prefrontal cortex and striatum of newborn mice, offering a new direction for the treatment of PD [75] . ...
... Furthermore, L. plantarum decreased inflammation and corticosterone levels considerably. Compared to control mice, L. plantarum PS128 treatment significantly enhanced dopamine and serotonin levels in the prefrontal cortex and striatum [27]. Also, the daily administration of L. plantarum may lead to a decrease in depressive symptoms and an improvement in deep sleep quality [28]. ...
Article
Full-text available
The gut–brain axis is a bidirectional relationship between the microbiota and the brain; genes related to the brain and gut synaptic formation are similar. Research on the causal effects of gut microbiota on human behavior, brain development, and function, as well as the underlying molecular processes, has emerged in recent decades. Probiotics have been shown in several trials to help reduce anxiety and depressive symptoms. Because of this, probiotic combinations have been tested in in vitro models to see whether they might modulate the gut and alleviate depression and anxiety. Therefore, we sought to determine whether a novel formulation might affect the pathways controlling anxiety and depression states and alter gut barrier activities in a 3D model without having harmful side effects. Our findings indicate that B. bifidum novaBBF7 10 mg/mL, B. longum novaBLG2 5 mg/mL, and L. paracasei TJB8 10 mg/mL may influence the intestinal barrier and enhance the synthesis of short-chain fatty acids. Additionally, the probiotics studied did not cause neuronal damage and, in combination, exert a protective effect against the condition of anxiety and depression triggered by L-Glutamate. All these findings show that probiotics can affect gut function to alter the pathways underlying anxiety and depression.
... A number of psychobiotics have shown their potential to positively impact ELS-induced consequences. Liu et al. found that the administration of a Lactiplantibacillus plantarum strain in mice subjected to maternal separation significantly reduced inflammation while increasing levels of serotonin in multiple areas of the brain [43]. Another group has also shown that supplementation with a probiotic formulation containing Lactobacillus helveticus and Lacticaseibacillus rhamnosus alleviates the deleterious impacts of ELS on the fear retention, extinction trajectory and neuronal activation of the brain [44]. ...
Article
Full-text available
The bidirectional relationship between the gut microbiota and the nervous system is known as the microbiota–gut–brain axis (MGBA). The MGBA controls the complex interactions between the brain, the enteric nervous system, the gut-associated immune system, and the enteric neuroendocrine systems, regulating key physiological functions such as the immune response, sleep, emotions and mood, food intake, and intestinal functions. Psychobiotics are considered tools with the potential to modulate the MGBA through preventive, adjunctive, or curative approaches, but their specific mechanisms of action on many aspects of health are yet to be characterized. This narrative review and perspectives article highlights the key paradigms needing attention as the scope of potential probiotics applications in human health increases, with a growing body of evidence supporting their systemic beneficial effects. However, there are many limitations to overcome before establishing the extent to which we can incorporate probiotics in the management of neuropsychiatric disorders. Although this article uses the term probiotics in a general manner, it remains important to study probiotics at the strain level in most cases.
... Pups were placed together on a heating pad maintained at 37 °C during the separation period. Maternal deprivation during hypothalamic-pituitary-axis development (PD2 to has been widely demonstrated to determine long-lasting consequences in offspring behaviors and physiology [8,[18][19][20]. Members of the control group were left undisturbed with their mother. ...
Article
Full-text available
Background Intestinal microbial composition not only affects the health of the gut but also influences centrally mediated systems involved in mood, through the “gut-brain” axis, a bidirectional communication between gut microbiota and the brain. In this context, the modulation of intestinal microbiota and its metabolites through the administration of probiotics seems to represent a very promising approach in the treatment of the central nervous system alterations. Early postnatal life is a critical period during which the brain undergoes profound and essential modulations in terms of maturation and plasticity. Maternal separation (MS), i.e., the disruption of the mother–pup interaction, represents a pivotal paradigm in the study of stress-related mood disorders, by inducing persistent changes in the immune system, inflammatory processes, and emotional behavior in adult mammals. Results We conducted experiments to investigate whether sustained consumption of a multi-strain probiotic formulation by adult male mice could mitigate the effects of maternal separation. Our data demonstrated that the treatment with probiotics was able to totally reverse the anxiety- and depressive-like behavior; normalize the neuro-inflammatory state, by restoring the resting state of microglia; and finally induce a proneurogenic effect. Mice subjected to maternal separation showed changes in microbiota composition compared to the control group that resulted in permissive colonization by the administered multi-strain probiotic product. As a consequence, the probiotic treatment also significantly affected the production of SCFA and in particular the level of butyrate. Conclusion Gut microbiota and its metabolites mediate the therapeutic action of the probiotic mix on MS-induced brain dysfunctions. Our findings extend the knowledge on the use of probiotics as a therapeutic tool in the presence of alterations of the emotional sphere that significantly impact on gut microbiota composition.
Article
Beynin %60’ı yağdan oluşur ve hücre düzeyinde oksidatif stres sonucunda oluşan serbest radikallerin vereceği hasara açık bir yapıdır. Nöronlarda üretilen başlıca serbest radikaller, süperoksit ve nitrik oksittir. Serbest radikallerin birikimi DNA oksidasyonuna ve DNA onarım mekanizmalarının bozulmasına neden olabilir; bu gibi hücresel değişiklikler nöronal işlev bozukluğuna, işlevsel ve yapısal nöroplastisiteye zarar verebilmektedir. Erken beyin gelişimini etkileyen faktörlerin başında beslenme gelmekte ve beslenme şekli hayat boyu hücre yenileme ve onarımını etkilemeyi sürdürmektedir. Bu derlemede oksidatif stresin moleküler düzeyde hücreye etkilerinin açıklanması ve gıdalardaki bazı besin bileşenleriyle, biyoaktif maddelerin beyin hücrelerine ve dolayısıyla bilişsel fonksiyonlara etkilerinin açıklanması hedeflenmiştir. Omega 3 yağ asitlerinin, vitaminlerin ve minerallerin, kolin, polifenoller gibi biyoaktif bileşenlerle psikobiyotiklerin, oksidatif hasara karşı hücre onarımına destek vererek, bilişsel fonksiyonu olumlu etkilediği çeşitli araştırmalarda belirlenmiştir. Bu derlemede öne çıkan besin bileşenleriyle, biyoaktif maddeler ve etki mekanizmaları mümkün olabildiğince açıklanmıştır.
Chapter
There are over 100 trillion microflorae in the human gut which engage in multiple interactions with human health during the whole life span. They influence human physiology, nutrition, metabolism and immunity. There is a two-way connection between the gut and brain known as gut-brain axis through which it influences the physiological, behavioural and cognitive functions of brain. This research focuses on the gut-brain axis, a bidirectional communication pathway between the gut and the brain that impacts brain function through vagus nerve and HPA axis and the metabolites such as neurotransmitters and SCFAs. The disruption in composition and relative abundance of gut microbiota known as dysbiosis leads to pathogenesis of several neurological disorders such as Alzheimer’s disease, Parkinson’s disease and autism. The individuals with neurological disorders presented with altered composition of gut microbes and its metabolites which varies from the normal individuals. This altered behaviour of gut microbes can be influenced or changed by supplementing with a bioactive live microorganisms known as probiotics. This study explores the potential of manipulating gut microbiota through probiotics to improve neurological function and potentially treat these disorders.
Article
Background Accumulating data show that probiotics may be beneficial for reducing depressive, anxiety, and stress symptoms. However, the best combinations and species of probiotics have not been identified. The objective of our study was to assess the most effective combinations and components of different probiotics through network meta-analysis. Method A systematic search of four databases, PubMed, Web of Science, Cochrane, and Embase, was conducted from inception to 11 January 2024. The GRADE framework was used to assess the quality of evidence contributing to each network estimate. Results We deemed 45 trials eligible, these included 4053 participants and 10 types of interventions. The quality of evidence was rated as high or moderate. The NMA revealed that Bifidobacterium exhibited a greater probability of being the optimal probiotic species for improving anxiety symptoms (SMD = −0.80; 95% CI −1.49 to −0.11), followed by Lactobacillus (SMD = −0.49; 95% CI −0.85 to −0.12). In addition, for multiple strains, compared with the other interventions, Lactobacillus + Bifidobacterium (SMD = −0.41; 95% CI −0.73 to −0.10) had a positive effect on depression. Conclusion The NMA revealed that Lactobacillus and Bifidobacterium had prominent efficacy in the treatment of individuals with anxiety, depression, and combination of Lactobacillus + Bifidobacterium had a similar effect. With few direct comparisons available between probiotic species, this NMA may be instrumental in shaping the guidelines for probiotic treatment of psychological disorders.
Article
Full-text available
The gut-brain-microbiota axis is increasingly recognized as an important regulator of intestinal physiology. Exposure to psychological stress causes activation of the hypothalamic-pituitary-adrenal (HPA)-axis and causes altered intestinal barrier function, intestinal dysbiosis and behavioral changes. The primary aim of this study was to determine if the effects of psychological stress on intestinal physiology and behavior, including anxiety and memory, are mediated by the adaptive immune system. Furthermore, we wanted to determine whether treatment with probiotics would normalize these effects. Here we demonstrate that B- and T-cell deficient Rag1(-/-) mice displayed altered baseline behaviors, including memory and anxiety, accompanied by an overactive HPA-axis, increased intestinal secretory state, dysbiosis, and decreased hippocampal c-fos expression. Both local (intestinal physiology and microbiota) and central (behavioral and hippocampal c-fos) changes were normalized by pretreatment with probiotics, indicating an overall benefit on health conferred by changes in the microbiota, independent of lymphocytes. Taken together, these findings indicate a role for adaptive immune cells in maintaining normal intestinal and brain health in mice, and show that probiotics can overcome this immune-mediated deficit in the gut-brain-microbiota axis.
Article
Full-text available
Early-life experience plays a major role in the stress response throughout life. Neonatal maternal separation (MS) is an animal model of depression with an altered serotonergic response. We hypothesize that this alteration may be caused by differences in 5-HT1A receptor and serotonin transporter (SERT) mRNA expression in brain areas involved in the control of emotions, memory, and fear as well as in regions controlling the central serotonergic tone. To test this, Sprague-Dawley rats were subjected to MS for 3 h daily during postnatal days 2-12. As control, age matched rats were non-separated (NS) from their dams. When animals reached adulthood (11-13 weeks) brain was extracted and mRNA expression of 5-HT1A receptor in amygdala, hippocampus and dorsal raphé nucleus (DRN) and SERT in the DRN was analyzed through in situ hybridisation. Densitometric analysis revealed that MS increased 5-HT1A receptor mRNA expression in the amygdala, and reduced its expression in the DRN, but no changes were observed in the hippocampus in comparison to NS controls. Also, MS reduced SERT mRNA expression in the DRN when compared to NS rats. These results suggest that early-life stress induces persistent changes in 5-HT1A receptor and SERT mRNA expression in key brain regions involved in the development of stress-related psychiatric disorders. The reduction in SERT mRNA indicates an alteration that is in line with clinical findings such as polymorphic variants in individuals with higher risk of depression. These data may help to understand how early-life stress contributes to the development of mood disorders in adulthood.
Article
The intestinal microbiota consists of a vast bacterial community that resides primarily in the lower gut and lives in a symbiotic relationship with the host. A bidirectional neurohumoral communication system, known as the gut-brain axis, integrates the host gut and brain activities. Here, we describe the recent advances in our understanding of how the intestinal microbiota communicates with the brain via this axis to influence brain development and behaviour. We also review how this extended communication system might influence a broad spectrum of diseases, including irritable bowel syndrome, psychiatric disorders and demyelinating conditions such as multiple sclerosis.
Article
Background Accumulating evidence suggests that commensal bacteria consumption has the potential to have a positive impact on stress-related psychiatric disorders. However, the specific bacteria influencing behaviors related to anxiety and depression remain unclear. To this end, we compared the effects of two different Bifidobacteria on anxiety and depression-like behavior; an antidepressant was also used as a comparator.Methods Innately anxious BALB/c mice received daily Bifidobacterium longum (B.) 1714, B. breve 1205, the antidepressant escitalopram or vehicle treatment for 6 weeks. Behavior was assessed in stress-induced hyperthermia test, marble burying, elevated plus maze, open field, tail suspension test, and forced swim test. Physiological responses to acute stress were also assessed.Key ResultsBoth Bifidobacteria and escitalopram reduced anxiety in the marble burying test; however, only B. longum 1714 decreased stress-induced hyperthermia. B. breve 1205 induced lower anxiety in the elevated plus maze whereas B. longum 1714 induced antidepressant-like behavior in the tail suspension test. However, there was no difference in corticosterone levels between groups.Conclusions & InferencesThese data show that these two Bifidobacteria strains reduced anxiety in an anxious mouse strain. These results also suggest that each bacterial strain has intrinsic effects and may be beneficially specific for a given disorder. These findings strengthen the role of gut microbiota supplementation as psychobiotic-based strategies for stress-related brain-gut axis disorders, opening new avenues in the field of neurogastroenterology.
Article
Neurodevelopmental disorders, including autism spectrum disorder (ASD), are defined by core behavioral impairments; however, subsets of individuals display a spectrum of gastrointestinal (GI) abnormalities. We demonstrate GI barrier defects and microbiota alterations in the maternal immune activation (MIA) mouse model that is known to display features of ASD. Oral treatment of MIA offspring with the human commensal Bacteroides fragilis corrects gut permeability, alters microbial composition, and ameliorates defects in communicative, stereotypic, anxiety-like and sensorimotor behaviors. MIA offspring display an altered serum metabolomic profile, and B. fragilis modulates levels of several metabolites. Treating naive mice with a metabolite that is increased by MIA and restored by B. fragilis causes certain behavioral abnormalities, suggesting that gut bacterial effects on the host metabolome impact behavior. Taken together, these findings support a gut-microbiome-brain connection in a mouse model of ASD and identify a potential probiotic therapy for GI and particular behavioral symptoms in human neurodevelopmental disorders.
Article
Bacterial colonisation of the gut plays a major role in postnatal development and maturation of key systems that have the capacity to influence central nervous system (CNS) programming and signaling, including the immune and endocrine systems. Individually, these systems have been implicated in the neuropathology of many CNS disorders and collectively they form an important bidirectional pathway of communication between the microbiota and the brain in health and disease. Regulation of the microbiome-brain-gut axis is essential for maintaining homeostasis, including that of the CNS. Moreover, there is now expanding evidence for the view that commensal organisms within the gut play a role in early programming and later responsivity of the stress system. Research has focused on how the microbiota communicates with the CNS and thereby influences brain function. The routes of this communication are not fully elucidated but include neural, humoral, immune and metabolic pathways. This view is underpinned by studies in germ-free animals and in animals exposed to pathogenic bacterial infections, probiotic agents or antibiotics which indicate a role for the gut microbiota in the regulation of mood, cognition, pain and obesity. Thus, the concept of a microbiome-brain-gut axis is emerging which suggests that modulation of the gut microflora may be a tractable strategy for developing novel therapeutics for complex stress-related CNS disorders where there is a huge unmet medical need.